Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
about
Proteinaceous Molecules Mediating Bifidobacterium-Host InteractionsTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseClaudins in intestines: Distribution and functional significance in health and diseasesCan probiotics benefit children with autism spectrum disorders?Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitisCan probiotics modulate human disease by impacting intestinal barrier function?Gut microbiota, probiotics, and human healthSmall intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitisMicroecology, intestinal epithelial barrier and necrotizing enterocolitis.Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitisBranched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model.Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiotaBifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis.Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice.Microbial ecosystems therapeutics: a new paradigm in medicine?Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunitSynergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.The composition of the gut microbiota throughout life, with an emphasis on early life.Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants.Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions.Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats.Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis.The role of intestinal epithelial barrier function in the development of NEC.Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria.Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1β-Induced Inflammation: A Transcription Profiling Analysis.Intestinal microbiota and its relationship with necrotizing enterocolitis.Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.Immature oxidative stress management as a unifying principle in the pathogenesis of necrotizing enterocolitis: insights from an agent-based model.Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestinePrevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature InfantProbiotics in early life: a preventative and treatment approach.Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function.Recent advances in small bowel diseases: Part I.Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC ModelThe suckling rat as a model for immunonutrition studies in early life.Bifidobacterium adolescentis protects against necrotizing enterocolitis and upregulates TOLLIP and SIGIRR in premature neonatal rats.Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis.
P2860
Q26740603-C46E16E8-11BD-4CB3-B565-EF86C4B340C9Q26771122-8208DBBF-A603-4FA6-B449-1E1B4C85B3F8Q27000548-B0222310-6CD7-4FBC-BA76-6D6A4E6356C2Q28076833-27717DDE-FC78-4092-9A26-D8B3FA2DEFDFQ28565067-94B4E578-50B7-45F2-978C-FBDD8AA531E8Q28817192-2BF364DF-5AB7-48C5-BBAE-10612840674DQ33666412-AA63CF5F-325E-42E4-9754-F662687C522DQ33721659-896DF7B3-5537-4E81-BD7F-6E29915179BCQ33730542-0948B6C3-5540-49AB-B086-AC5A606CB012Q34097563-C71228FA-A517-4ED1-B11D-9529B5118EE8Q34110669-A1758C0A-CB38-43E3-A87E-47E89D6A89B0Q34207172-50802213-4EC5-461A-BF75-B78A49597617Q34360448-FB313286-32C6-4869-B7FA-42E75CE183ADQ34388382-9D18C69E-2653-44E8-8DF6-FEA5A5189B91Q34519313-C3F7C089-7DF4-4619-AFA7-C86D303D8E20Q34525865-CCDD3303-803A-47BF-B901-E4AFC1AFE857Q34746651-C0CE73F9-BCF6-4BF3-8FA6-8C6DFFD181EFQ35044607-6CB72EEE-4D98-45F4-9894-DE895AAA9BCDQ35056256-B2F02C79-DF2A-403B-B573-589533822FD0Q35131051-900C8B80-30B8-422F-B69A-62F189393B95Q35150607-82E4520E-3310-4105-8F5E-A656BE07C7A1Q35152314-06D83913-CE10-4CCE-98AB-08AC9B62B46BQ35168957-6DAB0A3E-1C79-40CA-8975-1FAEFCA5E1C1Q35318848-B39E3ABB-6503-43DA-8045-3D5457B6A988Q35550764-0CCB60D4-0CF3-4026-909D-44A66A5ED35EQ35556323-90751F5E-69B2-484E-B23A-9C1310C89B55Q35612905-77698CE3-7303-408B-9B89-0ED889D9C937Q35636352-18590D58-9974-4939-879C-FB43D439621FQ35788266-035FA20E-C897-4C67-A9D9-EF48F99D5CA3Q35799174-F0FFEC3D-0CE5-454E-8E22-02F84B3E68CBQ35849435-1E078C28-584A-4A4F-BD67-14DE79148B85Q35922759-78B87E72-1D7F-438E-B77E-9560132EDF4CQ35958581-841FC6B1-0B0E-4C02-9F0C-8E41E15D03EFQ36014389-E70BA6E5-B4E4-4E2C-9EC9-7E2CA87C1348Q36055022-9600F946-24B5-4899-94E3-19C0FBE28189Q36093331-864D9EEB-D149-47F2-A44E-E07D0C8DC8ADQ36110095-5C0E5915-75AA-44CB-9825-77A71DC584E8Q36152172-528D00DE-53B1-4BFA-9875-989DAF82CDD7Q36241201-482FC657-E1B6-4D03-8F19-5FEEDAB449F1Q36309520-86054014-1AE0-45E6-AE55-121DCC5DCE3D
P2860
Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@en
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@nl
type
label
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@en
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@nl
prefLabel
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@en
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@nl
P2093
P2860
P356
P1476
Bifidobacterium bifidum improv ...... of necrotizing enterocolitis.
@en
P2093
Bohuslav Dvorak
Katerina Dvorak
Kelly M Arganbright
Ludmila Khailova
Masako Yajima
Melissa D Halpern
Toshi Kinouchi
P2860
P304
P356
10.1152/AJPGI.00141.2009
P577
2009-11-01T00:00:00Z